- Home
- WST vs SOLV Comparison
WST vs SOLV Comparison
Compare WST & SOLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WST
- SOLV
- Stock Information
- Founded
- WST 1923
- SOLV 2023
- Country
- WST United States
- SOLV United States
- Employees
- WST N/A
- SOLV N/A
- Industry
- WST Medical/Dental Instruments
- SOLV
- Sector
- WST Health Care
- SOLV
- Exchange
- WST Nasdaq
- SOLV NYSE
- Market Cap
- WST 15.2B
- SOLV 12.6B
- IPO Year
- WST N/A
- SOLV N/A
- Fundamental
- Price
- WST $214.58
- SOLV $66.74
- Analyst Decision
- WST Strong Buy
- SOLV Hold
- Analyst Count
- WST 6
- SOLV 9
- Target Price
- WST $349.00
- SOLV $79.29
- AVG Volume (30 Days)
- WST 1.0M
- SOLV 884.5K
- Earning Date
- WST 04-24-2025
- SOLV 05-08-2025
- Dividend Yield
- WST 0.39%
- SOLV N/A
- EPS Growth
- WST N/A
- SOLV N/A
- EPS
- WST 6.37
- SOLV 2.76
- Revenue
- WST $2,895,800,000.00
- SOLV $8,254,000,000.00
- Revenue This Year
- WST $1.24
- SOLV $2.37
- Revenue Next Year
- WST $6.56
- SOLV N/A
- P/E Ratio
- WST $33.44
- SOLV $23.73
- Revenue Growth
- WST N/A
- SOLV 0.69
- 52 Week Low
- WST $187.43
- SOLV $47.16
- 52 Week High
- WST $372.79
- SOLV $85.92
- Technical
- Relative Strength Index (RSI)
- WST 50.21
- SOLV N/A
- Support Level
- WST $204.79
- SOLV N/A
- Resistance Level
- WST $215.05
- SOLV N/A
- Average True Range (ATR)
- WST 7.23
- SOLV 0.00
- MACD
- WST 1.16
- SOLV 0.00
- Stochastic Oscillator
- WST 63.32
- SOLV 0.00
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
About SOLV SOLVENTUM CORP
Solventum Corp is an independent healthcare company with a primary focus on addressing healthcare challenges. Its diverse product portfolio spans the healthcare industry, including medical solutions, oral care, health information systems, and separation and purification sciences.